Management and outcome of tuberculosis patients who fail treatment under routine programme conditions in Malawi

International Journal of Tuberculosis and Lung Disease

Volumn 7, Issue 11, 2003, Pages 1040-1044

  Harries, Anthony D ^a   Nyirenda, T E ^a,b   Kemp, J R ^c   Squire, B S ^c   Godfrey Faussett, P ^d   Salaniponi, F M L ^a  

^a National Tuberculosis Control Programme Malawi   (Malawi)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Anti tuberculosis treatment; Failure; Malawi

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; DRUG SENSITIVITY; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALAWI; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, MICROBIAL; ISONIAZID; MALAWI; MYCOBACTERIUM TUBERCULOSIS; RETREATMENT; RETROSPECTIVE STUDIES; SPUTUM; TREATMENT FAILURE; TUBERCULOSIS, PULMONARY;

EID: 0242667891     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Becerra M C, Freeman J, Bayona J, et al. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2000; 4: 108-114.
2. Trébucq A, Anagonou S, Gninafon M, Lambregts K, Boulahbal F. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Benin after 12 years of short-course chemotherapy. Int J Tuberc Lung Dis 1999; 3: 466-470.
3. Rieder H L, Arnadottir T, Trébucq A, Enarson D A. Tuberculosis treatment: dangerous regimens? Int J Tuberc Lung Dis 2001; 5: 1-3.
4. World Health Organization. Treatment of tuberculosis. Guidelines for national programmes. 2nd ed. WHO/TB/97.220. Geneva: WHO, 1997.
5. Kwanjana J H, Harries A D, Gausi F, Nyangulu D S, Salaniponi F M L. TB-HIV seroprevalence in patients with tuberculosis in Malawi. Malawi Med J 2001; 13: 7-10.
6. Jenkins P A, Duddridge L R, Collins C H, Yates M D. Mycobacteria. In: Collins C H, Grange J M, eds. Isolation and identification of micro-organisms of medical and veterinary importance. London, UK: Academic Press, 1985: 275-296.
7. Warndorff D K, Yates M, Ngwira B, et al. Trends in anti-tuberculosis drug resistance in Karonga District, Malawi, 1986-1998. Int J Tuberc Lung Dis 2000; 4: 752-757.